| P50 | author | Arina Ten Cate-Hoek | Q115129823 |
| | Martin H Prins | Q121477633 |
| | Hugo ten Cate | Q37384164 |
| | Michael Nagler | Q57079400 |
| P2860 | cites work | Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines | Q24633053 |
| | Outpatient treatment of deep venous thrombosis in diverse inner-city patients | Q33337140 |
| | What is a clinical pathway? Development of a definition to inform the debate | Q33589276 |
| | Risk factors for venous thrombosis - current understanding from an epidemiological point of view. | Q34114450 |
| | Risk of recurrence after a first episode of symptomatic venous thromboembolism provoked by a transient risk factor: a systematic review | Q34145656 |
| | Risk assessment for recurrent venous thrombosis | Q34153343 |
| | Thrombophilia, clinical factors, and recurrent venous thrombotic events | Q34419598 |
| | Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report | Q34513594 |
| | D-dimer testing to determine the duration of anticoagulation therapy | Q34576728 |
| | Cost savings and effectiveness of outpatient treatment with low molecular weight heparin of deep vein thrombosis in a community hospital. | Q35822705 |
| | 6 versus 30 months anticoagulation for recurrent venous thrombosis in patients with high factor VIII | Q79642715 |
| | Interobserver agreement on ultrasound measurements of residual vein diameter, thrombus echogenicity and Doppler venous flow in patients with previous venous thrombosis | Q82087256 |
| | Thrombophilia and venous thromboembolism. International consensus statement. Guidelines according to scientific evidence. | Q36118192 |
| | Post-treatment residual thrombus increases the risk of recurrent deep vein thrombosis and mortality | Q36534259 |
| | Defining pathways | Q36605413 |
| | Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy | Q36841584 |
| | A Validated Risk Score for Venous Thromboembolism Is Predictive of Cancer Progression and Mortality | Q37091111 |
| | Residual venous thrombosis as predictive factor for recurrent venous thromboembolim in patients with proximal deep vein thrombosis: a sytematic review | Q37849816 |
| | Residual vein obstruction to predict the risk of recurrent venous thromboembolism in patients with deep vein thrombosis: a systematic review and meta-analysis. | Q37850495 |
| | Venous thrombosis: understanding the paradoxes of recurrence | Q38117733 |
| | Thrombosis: a major contributor to the global disease burden | Q38258811 |
| | Mild antithrombin deficiency and risk of recurrent venous thromboembolism: a prospective cohort study. | Q38442595 |
| | Sex difference in risk of second but not of first venous thrombosis: paradox explained | Q39328528 |
| | Markers of coagulation, fibrinolysis and inflammation in relation to post-thrombotic syndrome | Q39611973 |
| | Fibrin fragment D-dimer and the risk of future venous thrombosis | Q40625965 |
| | Excess long-term mortality in outpatient deep venous thrombosis patients managed in an ambulatory care setting | Q40628993 |
| | Sex difference in the risk of recurrent venous thrombosis: a detailed analysis in four European cohorts. | Q41485760 |
| | Outpatient management of DVT using low molecular weight heparin and a hospital outreach service | Q44029837 |
| | Optimizing transition of care through the facilitation of a pharmacist-managed deep vein thrombosis treatment program | Q46202395 |
| | Combination of D-dimer, F1+2 and residual vein obstruction as predictors of VTE recurrence in patients with first VTE episode after OAT withdrawal | Q46808776 |
| | C-reactive protein, obesity, and the risk of arterial and venous thrombosis | Q48720506 |
| | The long-term recurrence risk of patients with unprovoked venous thromboembolism: an observational cohort study. | Q51785468 |
| | Residual thrombosis on ultrasonography to guide the duration of anticoagulation in patients with deep venous thrombosis: a randomized trial. | Q51831890 |
| | Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. | Q51903642 |
| | A simple ultrasound approach for detection of recurrent proximal-vein thrombosis. | Q52885406 |
| | Implementation of a clinical pathway for emergency department out-patient management of deep vein thrombosis. | Q53452300 |
| | Clinical predictors of recurrent venous thromboembolism: a single institute experience in Korea. | Q53536463 |
| | D-dimer as a risk factor for deep vein thrombosis: the Leiden Thrombophilia Study. | Q53978604 |
| | Outpatient-based treatment protocols in the management of venous thromboembolic disease. | Q54000073 |
| | Residual venous obstruction, alone and in combination with D-dimer, as a risk factor for recurrence after anticoagulation withdrawal following a first idiopathic deep vein thrombosis in the prolong study | Q56989052 |
| | D-dimer and factor VIII are independent risk factors for recurrence after anticoagulation withdrawal for a first idiopathic deep vein thrombosis | Q56994021 |
| | D-dimer levels in combination with residual venous obstruction and the risk of recurrence after anticoagulation withdrawal for a first idiopathic deep vein thrombosis | Q56999261 |
| | Outpatient treatment of deep venous thrombosis: A clinical care pathway managed by the emergency department | Q59920546 |
| | Thrombophilieabklärung | Q62383680 |
| | Definition of post-thrombotic syndrome of the leg for use in clinical investigations: a recommendation for standardization | Q64386237 |
| | Detection of deep-vein thrombosis by real-time B-mode ultrasonography | Q69483641 |
| | Effectiveness and economic impact associated with a program for outpatient management of acute deep vein thrombosis in a group model health maintenance organization | Q73102601 |
| | D-dimer levels and risk of recurrent venous thromboembolism | Q73864376 |
| | Normalization rates of compression ultrasonography in patients with a first episode of deep vein thrombosis of the lower limbs: association with recurrence and new thrombosis | Q74097496 |
| | Integrated care pathways | Q74171240 |
| | The diagnostic value of compression ultrasonography in patients with suspected recurrent deep vein thrombosis | Q78294352 |
| | Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism | Q78670334 |
| P433 | issue | 2 | |
| P921 | main subject | deep vein thrombosis | Q1762339 |
| | anticoagulant | Q215118 |
| | thrombosis | Q261327 |
| P304 | page(s) | 299-309 | |
| P577 | publication date | 2018-02-03 | |
| P1433 | published in | Research and Practice in Thrombosis and Haemostasis | Q50817799 |
| P1476 | title | Risk factors for recurrence in deep vein thrombosis patients following a tailored anticoagulant treatment incorporating residual vein obstruction. | |
| P478 | volume | 2 | |